Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2026Journal of Clinical MedicineOpen Access

Factor XI and XIa Inhibitors: A State-of-the-Art Review Across Clinical Indications

View Full Paper
Ask AI
Bookmark
Share

Authors

EOErmioni OikonomouMGMark GoldinASAlex C. Spyropoulos

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Oikonomou et al. (2026) studied this question.

synapsesocial.com/papers/6ab9b4a37822ec8fc3d8e77dhttps://doi.org/10.3390/jcm15197431
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacology and Clinical Development of Factor XI Inhibitors2023 · 143 citations
  2. 2Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas2025 · 2 citations
  3. 3A New Therapeutic Principle in Anticoagulation2024 · 1 citations
  4. 4Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence2022 · 84 citations
  5. 5Factor XI/XIa Inhibitors: A New Approach to Anticoagulation2023 · 3 citations